Estimation of the major cardiovascular events prevention with Inclisiran
Alberto Cordero, Carlos G. Santos‐Gallego, Lorenzo Fácila, Moisés Rodríguez‐Mañero, Vicente Bertomeu‐González, José M. Castellano, José Seijas‐Amigo, Julio Núñez, Pilar Zuazola, José Ramón González‐Juanatey, Juan J. Badimón
Topics & Concepts
MaceMedicineInternal medicineClinical endpointRandomized controlled trialAlirocumabPlaceboPCSK9Incidence (geometry)CholesterolApolipoprotein BLipoproteinMyocardial infarctionPercutaneous coronary interventionLDL receptorPathologyOpticsAlternative medicinePhysicsApolipoprotein A1Lipoproteins and Cardiovascular HealthPeroxisome Proliferator-Activated ReceptorsAtherosclerosis and Cardiovascular Diseases